These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The pathophysiology of angina pectoris and the effect of lidoflazine. Gobel FL; Nordstrom LA; Nelson RR; Wang Y Circulation; 1982 Jan; 65(1 Pt 2):I27-32. PubMed ID: 7030519 [TBL] [Abstract][Full Text] [Related]
23. Inappropriate coronary vasoconstriction in patients with coronary artery disease: a role for nifedipine? Gunther S; Green L; Muller JE; Mudge GH; Grossman W Am J Cardiol; 1979 Oct; 44(5):793-7. PubMed ID: 386763 [TBL] [Abstract][Full Text] [Related]
24. Increased coronary tone in exertional angina: the beneficial effects of calcium antagonists. Specchia G; Ardissino D; Ghio S; Barberis P; Colombo ML; De Servi S Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 5():893-7. PubMed ID: 2076396 [TBL] [Abstract][Full Text] [Related]
36. Aspects of the medical therapy of angina pectoris. Maseri A Drugs; 1991; 42 Suppl 1():28-30. PubMed ID: 1718691 [TBL] [Abstract][Full Text] [Related]
37. [Epicardial coronary vasomotor action as a physiopathologic mechanism of myocardial ischemia]. Gaspar J; Horwitz S Arch Inst Cardiol Mex; 1983; 53(5):455-67. PubMed ID: 6139980 [No Abstract] [Full Text] [Related]